Our science for your future
SEQENS (seqens.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Manufacturing brands, Healthcare brands, Other brands, in the 71st percentile of 28075 Manufacturing brands.
SEQENS is a global company operating in Health, Personal Care, and Specialty Ingredients. It operates 16 production sites and 9 R&D centers worldwide, providing pharmaceutical APIs, intermediates, excipients, and custom specialty chemical ingredients. The company positions itself as an integrated global platform combining scientific expertise with large-scale manufacturing capacity, serving pharmaceutical, personal care, and industrial manufacturing clients, while emphasizing corporate social responsibility in its operations.
| Brand Name | SEQENS |
|---|---|
| Domain | seqens.com |
| Industry | Manufacturing, Healthcare |
| Main Competitors | Lonza (86/100), Cambrex (78/100), Siegfried Holding (75/100), Evonik (88/100), Novasep (82/100), DSM-Firmenich (82/100), Croda International (87/100), Dishman Carbogen Amcis |
Moz Domain Authority 37/100 vs category average 36 / leader 94 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,040,503 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "SEQENS is an integrated global leader in Health, Personal Care and Specialty Ingredients with 16 production sites and 9 R&D centres across the world," (Meta description: 24 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: WordPress, Ghost.
Social footprint: verified profiles on YouTube, LinkedIn, X (Twitter), Facebook, Instagram; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is SEQENS?", Claude could identify the brand as of October 2026. SEQENS is a French chemicals manufacturer specializing in pharmaceutical ingredients (APIs) and specialty chemicals, formed in 2017 from the merger of PCAS and Novasep's specialty chemicals business. It operates across several European and global sites, serving pharmaceutical, co Best known for Being a major European producer of pharmaceutical active ingredients (APIs) and fine chemicals.
When asked "Best brands similar to SEQENS?", Claude would recommend SEQENS as of October 2026. It's a well-known player in the European pharma chemicals and CDMO space, so it would come up in discussions of API manufacturers and specialty chemical companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
SEQENS's main competitors in Manufacturing: Lonza (86/100), Cambrex (78/100), Siegfried Holding (75/100), Evonik (88/100), Novasep (82/100).
Sources: Brand Analyzer scan
SEQENS has limited AI-search visibility, scoring 36/100 on Brand Analyzer's AI visibility composite (visibility 19, trust 39, recommendation 61). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: SEQENS official site
SEQENS offers pharmaceutical active pharmaceutical ingredients (APIs), chemical intermediates, excipients, and custom specialty chemical ingredients. These products serve health, personal care, and specialty industrial applications, supported by its global manufacturing and R&D network.
Sources: SEQENS official site
SEQENS scores 61/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Manufacturing options. Recommendation depends on crawlability, structured data, and category authority.
Sources: SEQENS official site
SEQENS is a global company operating as an integrated leader in Health, Personal Care, and Specialty Ingredients, with a worldwide network of 16 production sites and 9 R&D centers.
Sources: SEQENS official site
SEQENS manufactures pharmaceutical APIs, intermediates, excipients, and custom specialty chemical ingredients for use in pharmaceutical, personal care, and industrial applications. It combines scientific research and development with large-scale global manufacturing to supply these products to clients worldwide.
Sources: SEQENS official site
SEQENS can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: SEQENS official site
SEQENS' products and services are used by pharmaceutical companies, personal care brands, and industrial manufacturers that require APIs, intermediates, excipients, or custom specialty chemical ingredients for their manufacturing processes.
Sources: SEQENS official site
SEQENS is known for its integrated global platform in Health, Personal Care, and Specialty Ingredients, supported by 16 production sites and 9 R&D centers that allow it to manufacture pharmaceutical APIs, intermediates, excipients, and specialty chemical ingredients at scale.
Sources: SEQENS official site
SEQENS scores 36/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
SEQENS has a weak AI-visibility profile at 36/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (61/100) and its weakest is visibility (19/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,040,503 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 37/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify SEQENS from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to SEQENS: Sembcorp (79/100), Select Sires (79/100), Serotta (79/100), Sesotec (79/100).
A step up - brands to learn from: Zucchetti (81/100), Zucchetti (81/100).
Category leader: DHL (97/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.